A Post Hoc Analysis of D-THREO-METHYLPHENIDATE HYDROCHLORIDE (cas 19262-68-1) (Focalin) Versus d,l-threo-Methylphenidate Hydrochloride (Ritalin)
-
Add time:07/30/2019 Source:sciencedirect.com
ABSTRACTObjective:To evaluate clinical measures of the benefit/risk ratio in a post hoc analysis of a clinical trial of d-threo-methylphenidate hydrochloride (d-MPH) and d,l-threo-methylphenidate hydrochloride (d,l-MPH).
We also recommend Trading Suppliers and Manufacturers of D-THREO-METHYLPHENIDATE HYDROCHLORIDE (cas 19262-68-1). Pls Click Website Link as below: cas 19262-68-1 suppliers
Prev:Elaboration of AA-BB and AB-type Non-Isocyanate Polyurethanes (NIPUs) using a cross metathesis polymerization between methyl carbamate and methyl carbonate groups
Next:Transdermal patches for D-threo-methylphenidate (free base): Formulation aspects and in vivo pharmacokinetics) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Development of enantioselective gas chromatographic quantitation assay for dl-threo-methylphenidate in biological fluids08/05/2019
- Double-Blind, Randomized Trial of Dexmethylphenidate Hydrochloride for the Treatment of Sarcoidosis-Associated Fatigue08/04/2019
- Binding of d-threo-[11C]methylphenidate to the dopamine transporter in vivo: insensitivity to synaptic dopamine08/03/2019
- A Double-Blind, Placebo-Controlled Trial of Dexmethylphenidate Hydrochloride and d,l-threo-Methylphenidate Hydrochloride in Children With Attention-Deficit/Hyperactivity Disorder08/02/2019
- Comparative Pharmacodynamics and Plasma Concentrations of D-THREO-METHYLPHENIDATE HYDROCHLORIDE (cas 19262-68-1) After Single Doses of D-THREO-METHYLPHENIDATE HYDROCHLORIDE (cas 19262-68-1) and d,l-threo-Methylphenidate Hydrochloride in a Double-Blind, Placebo-Controlled, Crossover Laboratory School Study in Children With Attention-Deficit/Hyperactivity Disorder08/01/2019
- Transdermal patches for D-threo-methylphenidate (free base): Formulation aspects and in vivo pharmacokinetics07/31/2019
